SAN FRANCISCO–(BUSINESS WIRE)–The EVERY Company, a biotechnology leader pioneering precision fermentation for highly functional proteins, today announced that it has successfully closed on $55 million in Series D financing. The round was led by McWin Capital Partners, through the McWin Food Tech Fund, with participation from Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & Ag, New Agrarian, SOSV, and more.

Read more here.